Global Unresectable Hepatocellular Carcinoma Market Report By Treatment (Chemotherapy, Molecularly Targeted Therapy, Immunotherapy), By End-Use (Hospitals, Specialty Clinics, Cancer Centers, Research institutes)And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Unresectable Hepatocellular Carcinoma Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11212416

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Unresectable Hepatocellular Carcinoma Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.

Hepatocellular carcinoma is a type of primary liver cancer. It is highly angiogenic solid tumour characterized molecularly by cell-cycle dysregulation, aberrant angiogenesis, and evasion of apoptosis. It occurs most often in people with chronic liver diseases. The risk is higher in people with long term liver diseases, in people who drink large amounts of alcohol, and one who has an accumulation of fat in the liver. An unresectable hepatocellular carcinoma cannot be treated with surgeries, the treatment includes drug therapy, immunotherapy, radiotherapy, and destroying cancer with heat or cold.

Market Dynamics

Hepatocellular carcinoma is one of the most prevalent worldwide. It is associated with a very low 5-year survival rate. Very few patients with HCC qualify for surgical resection or liver transplantation, as more than half of all HCCs are diagnosed at an advanced stage of the disease. Asia contributes a particularly large prevalence of the global hepatocellular carcinoma (HCC), accounting for nearly two-thirds of the newly diagnosed. The majority of HCC patients are diagnosed at unresectable stages. Intraarterial therapy (IAT), specifically transarterial chemoembolization, is considered the standard of care in patients with unresectable HCC. Other recent options are sorafenib, regorafenib, nivolumab, lenvatinib, pembrolizumab, cabozantinib, and ramucirumab. However, there is no evidence that currently used anatomic response criteria are adequate for overall survival because tumour shrinkage is rarely observed in patients with unresectable HCC after IAT.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of unresectable hepatocellular carcinoma.

Market Segmentation

The entire unresectable hepatocellular carcinoma market has been sub-categorized into treatment and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Treatment

Chemotherapy
Molecularly Targeted Therapy
Immunotherapy

By End-Use

Hospitals
Specialty Clinics
Cancer Centers
Research institutes

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for unresectable hepatocellular carcinoma market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Unresectable Hepatocellular Carcinoma Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the unresectable hepatocellular carcinoma market include Eisai Co., Ltd, Bayer AG, Bristol- Myers Squibb Company, Sumitomo Dainippon Pharma Co., Ltd, Glaxosmithkline Plc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Unresectable Hepatocellular Carcinoma Market
       2.2. Global Unresectable Hepatocellular Carcinoma Market Snapshot

3 . UNRESECTABLE HEPATOCELLULAR CARCINOMA – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Unresectable Hepatocellular Carcinoma Market
       3.3. Market Restraints of Unresectable Hepatocellular Carcinoma Market
       3.4. Opportunities of Unresectable Hepatocellular Carcinoma Market
       3.5. Trends of Unresectable Hepatocellular Carcinoma Market
      3.6. Porter’s Five Force Analysis of Unresectable Hepatocellular Carcinoma Market
       3.7. Unresectable Hepatocellular Carcinoma Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Treatment
           3.7.2 Market Attractive Analysis by End-Use
           3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Unresectable Hepatocellular Carcinoma Value Chain Analysis
       4.2. Unresectable Hepatocellular Carcinoma Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Unresectable Hepatocellular Carcinoma Raw Material Manufactures List
           4.2.3. Price Trend of Unresectable Hepatocellular Carcinoma Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Unresectable Hepatocellular Carcinoma Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Unresectable Hepatocellular Carcinoma Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Unresectable Hepatocellular Carcinoma Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Unresectable Hepatocellular Carcinoma Market

6 . GLOBAL UNRESECTABLE HEPATOCELLULAR CARCINOMA MARKET ANALYSIS BY TREATMENT
       6.1 Overview by Treatment
       6.2 Global Unresectable Hepatocellular Carcinoma Market Analysis by Treatment
       6.3 Market Analysis of Chemotherapy by Regions
       6.4 Market Analysis of Molecularly Targeted Therapy by Regions
       6.6 Market Analysis of Immunotherapy by Regions

7 . GLOBAL UNRESECTABLE HEPATOCELLULAR CARCINOMA MARKET ANALYSIS BY END-USE
       7.1 Overview by End-Use
       7.2 Global Unresectable Hepatocellular Carcinoma Market Analysis by End-Use
       7.3 Market Analysis of Hospitals by Regions
       7.4 Market Analysis of Specialty Clinics by Regions
       7.5 Market Analysis of Cancer Centers by Regions
       7.6 Market Analysis of Research Institutes by Regions

8 . GLOBAL UNRESECTABLE HEPATOCELLULAR CARCINOMA MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Unresectable Hepatocellular Carcinoma Market Estimate by Market Segment
           8.3.3. North America Unresectable Hepatocellular Carcinoma Market Estimate by Country
           8.3.4. United State
           8.3.5. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Unresectable Hepatocellular Carcinoma Market Estimate by Market Segment
           8.4.3. Europe Unresectable Hepatocellular Carcinoma Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.8 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Unresectable Hepatocellular Carcinoma Market Estimate by Market Segment
           8.5.3. Asia Pacific Unresectable Hepatocellular Carcinoma Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
         8.5.8. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Unresectable Hepatocellular Carcinoma Market Estimate by Market Segment
           8.6.3. Latin America Unresectable Hepatocellular Carcinoma Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.8. Middle East & Africa
           8.8.1. Overview
           8.8.2. Middle East & Africa Unresectable Hepatocellular Carcinoma Market Estimate by Market Segment
           8.8.3. Middle East & Africa Unresectable Hepatocellular Carcinoma Market Estimate by Country
           8.8.4. Middle East
           8.8.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE UNRESECTABLE HEPATOCELLULAR CARCINOMA COMPANIES
       9.1. Unresectable Hepatocellular Carcinoma Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments

10 . COMPANY PROFILES OF UNRESECTABLE HEPATOCELLULAR CARCINOMA INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Eisai Co., Ltd.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Bayer AG
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Bristol- Myers Squibb Company
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Sumitomo Dainippon Pharma Co., Ltd.
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Glaxosmithkline Plc
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Unresectable Hepatocellular Carcinoma Report
Market Research Process
Market Research Methodology
Global Unresectable Hepatocellular Carcinoma Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Treatment
Market Attractiveness Analysis by End-Use
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Unresectable Hepatocellular Carcinoma Market Analysis by Treatment (USD MN)
Global Unresectable Hepatocellular Carcinoma Market Analysis in Chemotherapy by Geography (USD MN)
Global Unresectable Hepatocellular Carcinoma Market Analysis in Molecularly Targeted Therapy by Geography (USD MN)
Global Unresectable Hepatocellular Carcinoma Market Analysis in Immunotherapy by Geography (USD MN)
Global Unresectable Hepatocellular Carcinoma Market Analysis by End-Use (USD MN)
Global Unresectable Hepatocellular Carcinoma Market Analysis in Hospitals by Geography (USD MN)
Global Unresectable Hepatocellular Carcinoma Market Analysis in Specialty Clinics by Geography (USD MN)
Global Unresectable Hepatocellular Carcinoma Market Analysis in Cancer Centers by Geography (USD MN)
Global Unresectable Hepatocellular Carcinoma Market Analysis in Research Institutes by Geography (USD MN)
Latin America Unresectable Hepatocellular Carcinoma Market by Revenue
Middle East & Africa Unresectable Hepatocellular Carcinoma Market by Revenue
Recent Development in Unresectable Hepatocellular Carcinoma Industry
Company Market Share Analysis

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "